Trademark: 90392963
Word
GALENAGEN
Status
Pending
Status Code
734
Status Date
Tuesday, April 2, 2024
Serial Number
90392963
Mark Type
4000
Filing Date
Friday, December 18, 2020
Published for Opposition
Tuesday, August 10, 2021

Trademark Owner History
Galenagen, LLC - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the diagnosis, treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Antibacterial, antiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes; Medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; biological preparations for medical testing; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing; diagnostic biomarker reagents for medical testing; all the foregoing for the diagnosis and treatment of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders
44 Medical testing for diagnostic and treatment purposes; Medical consultations; medical testing for diagnostic treatment purposes in the fields of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; medical testing for diagnostic treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Medical diagnostic testing, monitoring and reporting services; performing diagnosis of diseases; Health care services, namely, the administration of medical assays for the detection of enzymes in humans
42 Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical research; Development of pharmaceuticals and medical devices for others; Providing temporary use of non-downloadable computer software that allows users to make determinations regarding neurological diseases, specifically baseline staging, data gathering and monitoring of early, middle and late stage neurological diseases; Design and development of medical assays for others; clinical research and development of treatments for viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; clinical research and development of treatments for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; clinical research and development of treatments for antibacterial, antiviral, and antifungal preparations for skin and wound healing; clinical research and development of disinfectants, antiseptics and antimicrobial cleansers for sanitation purposes; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body

Trademark Events
Apr 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Apr 2, 2024
Sou Extension 5 Granted
Apr 2, 2024
Sou Extension 5 Filed
Apr 2, 2024
Sou Teas Extension Received
Oct 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 2, 2023
Sou Extension 4 Granted
Oct 2, 2023
Sou Extension 4 Filed
Oct 2, 2023
Sou Teas Extension Received
Mar 31, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 29, 2023
Sou Extension 3 Granted
Mar 29, 2023
Sou Extension 3 Filed
Mar 29, 2023
Sou Teas Extension Received
Oct 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 30, 2022
Sou Extension 2 Granted
Sep 30, 2022
Sou Extension 2 Filed
Sep 30, 2022
Sou Teas Extension Received
Mar 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2022
Sou Extension 1 Granted
Mar 28, 2022
Sou Extension 1 Filed
Mar 28, 2022
Sou Teas Extension Received
Oct 5, 2021
Noa E-Mailed - Sou Required From Applicant
Aug 10, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 10, 2021
Published For Opposition
Jul 21, 2021
Notification Of Notice Of Publication E-Mailed
Jul 8, 2021
Approved For Pub - Principal Register
Jun 14, 2021
Assigned To Examiner
Mar 1, 2021
New Application Office Supplied Data Entered
Dec 22, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24